Supplementary Material for: Disease etiology impact on outcomes of hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: a real-world, multicenter study

  • Federico Rossari (寄稿者)
  • Toshifumi Tada (寄稿者)
  • G. Suda (寄稿者)
  • Shigeo Shimose (寄稿者)
  • Masatoshi Kudo (寄稿者)
  • Changhoon Yoo (寄稿者)
  • Jaekyung Cheon (寄稿者)
  • Fabian Finkelmeier (寄稿者)
  • Ho Yeong Lim (寄稿者)
  • Gianluca Masi (寄稿者)
  • Francesca Bergamo (寄稿者)
  • Elisabeth Amadeo (寄稿者)
  • Francesco Vitiello (寄稿者)
  • Takashi Kumada (寄稿者)
  • Hideki Iwamoto (寄稿者)
  • Tomoko Aoki (寄稿者)
  • Hong Jae Chon (寄稿者)
  • Vera Himmelsbach (寄稿者)
  • Massimo Iavarone (寄稿者)
  • Giuseppe Cabibbo (寄稿者)
  • Margarida Montes (寄稿者)
  • F. G. Foschi (寄稿者)
  • Caterina Vivaldi (寄稿者)
  • Caterina Soldà (寄稿者)
  • T. Sho (寄稿者)
  • Takashi Niizeki (寄稿者)
  • N. Nishida (寄稿者)
  • Christoph Steup (寄稿者)
  • Masashi Hirooka (寄稿者)
  • Kazuya Kariyama (寄稿者)
  • Joji Tani (寄稿者)
  • Masanori Atsukawa (寄稿者)
  • Koichi Takaguchi (寄稿者)
  • Ei Itobayashi (寄稿者)
  • Shinya Fukunishi (寄稿者)
  • Kunihiko Tsuji (寄稿者)
  • Toru Ishikawa (寄稿者)
  • Kazuto Tajiri (寄稿者)
  • Hironori Ochi (寄稿者)
  • Satoshi Yasuda (寄稿者)
  • Hidenori Toyoda (寄稿者)
  • Chikara Ogawa (寄稿者)
  • Takashi Nishimura (寄稿者)
  • Takeshi Hatanaka (寄稿者)
  • Satoru Kakizaki (寄稿者)
  • Noritomo Shimada (寄稿者)
  • Kazuhito Kawata (寄稿者)
  • Atsushi Hiraoka (寄稿者)
  • Fujimasa Tada (寄稿者)
  • Hideko Ohama (寄稿者)
  • Kazuhiro Nouso (寄稿者)
  • Asahiro Morishita (寄稿者)
  • Akemi Tsutsui (寄稿者)
  • Takuya Nagano (寄稿者)
  • Norio Itokawa (寄稿者)
  • Tomomi Okubo (寄稿者)
  • Michitaka Imai (寄稿者)
  • Hisashi Kosaka (寄稿者)
  • Atsushi Naganuma (寄稿者)
  • Yohei Koizumi (寄稿者)
  • Shinichiro Nakamura (寄稿者)
  • Masaki Kaibori (寄稿者)
  • Hiroko Iijima (寄稿者)
  • Yoichi Hiasa (寄稿者)
  • Mara Persano (寄稿者)
  • Silvia Foti (寄稿者)
  • Silvia Camera (寄稿者)
  • Bernardo Stefanini (寄稿者)
  • Mario Scartozzi (寄稿者)
  • Stefano Cascinu (寄稿者)
  • Andrea Casadei-Gardini (寄稿者)
  • Margherita Rimini (寄稿者)

データセット

検索結果

  • 2024

    Disease Etiology Impact on Outcomes of Hepatocellular Carcinoma Patients Treated with Atezolizumab plus Bevacizumab: A Real-World, Multicenter Study

    Rossari, F., Tada, T., Suda, G., Shimose, S., Kudo, M., Yoo, C., Cheon, J., Finkelmeier, F., Lim, H. Y., Presa, J., Masi, G., Bergamo, F., Amadeo, E., Vitiello, F., Kumada, T., Sakamoto, N., Iwamoto, H., Aoki, T., Chon, H. J. & Himmelsbach, V. & 54 others, Iavarone, M., Cabibbo, G., Montes, M., Foschi, F. G., Vivaldi, C., Soldà, C., Sho, T., Niizeki, T., Nishida, N., Steup, C., Hirooka, M., Kariyama, K., Tani, J., Atsukawa, M., Takaguchi, K., Itobayashi, E., Fukunishi, S., Tsuji, K., Ishikawa, T., Tajiri, K., Ochi, H., Yasuda, S., Toyoda, H., Ogawa, C., Nishimura, T., Hatanaka, T., Kakizaki, S., Shimada, N., Kawata, K., Hiraoka, A., Tada, F., Ohama, H., Nouso, K., Morishita, A., Tsutsui, A., Nagano, T., Itokawa, N., Okubo, T., Imai, M., Kosaka, H., Naganuma, A., Koizumi, Y., Nakamura, S., Kaibori, M., Iijima, H., Hiasa, Y., Persano, M., Foti, S., Camera, S., Stefanini, B., Scartozzi, M., Cascinu, S., Casadei-Gardini, A. & Rimini, M., 2024/04/10, In: Liver Cancer. 13, 5, p. 522-536 15 p.

    研究成果: ジャーナルへの寄稿学術論文査読

    Open Access
    6 被引用数 (Scopus)